OBJECT FOR THE REQUEST: A pharmacometric modelling service for selecting of a therapeutic dose based on data from Phase I clinical trials with OATD-01.
After collecting all the information regarding the request for proposal and after analyzing the completeness of the offers, the Commission concludes that the most advantageous offer meeting all the requirements contained in the request has presented:
Immeuble Genavenir 8 – 5,
rue Henri Desbruères 91 030 Evry Cedex,
Total price of the order execution: 117 868,00 EUR (517 464,09 PLN)
The Commission recommends the Management Board to perform the order in accordance with the offer submitted by PhInC Development.